Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study

Abstract Background Accumulating evidence indicates that SARS-CoV-2 infection is associated with a broad spectrum of post-acute COVID sequelae, including diabetes. While nirmatrelvir/ritonavir and molnupiravir have demonstrated efficacy in reducing acute COVID-19 severity, their protective effects a...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Zihao Guo, Yuchen Wei, Aimin Yang, Carlos King Ho Wong, Xi Xiong, Kailu Wang, Guozhang Lin, Huwen Wang, Chi Tim Hung, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Shi Zhao, Chris Ka Pun Mok, David S. C. Hui, Eng Kiong Yeoh, Ka Chun Chong
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-03-01
Rangatū:	BMC Medicine
Ngā marau:	Diabetes Hong Kong Molnupiravir Nirmatrelvir/ritonavir Post-acute COVID sequelae SARS-CoV-2
Urunga tuihono:	https://doi.org/10.1186/s12916-026-04791-2
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!